Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-28 02:08 | 2023-02-24 | TWLO | TWILIO INC | Lawson Jeff | Director, Officer, 10% owner - Chief Executive Officer | Services-Prepackaged Software | BUY | $63.26 | 158,081 | $10,000,109 | 226,397 | +231.4% |
| 2023-02-27 14:00 | 2023-02-23 | ET | Energy Transfer LP | WARREN KELCY L | Director, Officer - Executive Chairman | Natural Gas Transmission | BUY | $13.05 | 1,660,602 | $21,670,856 | 58,578,477 | +2.9% |
| 2023-02-28 01:20 | 2023-02-27 | OMGA | N/A | Flagship Pioneering Inc. | 10% owner | Other | BUY | $5.78 | 3,323,310 | $19,208,732 | 1,329,324 | +100.0% |
| 2023-02-27 17:56 | 2023-02-23 | BLBX | Blackboxstocks Inc. | KEPLER GUST | Director, Officer, 10% owner - President and CEO | Metal Mining | BUY | $3.00 | 1,130,002 | $3,390,006 | 3,462,070 | +48.5% |
| 2023-02-24 14:15 | 2023-02-23 | VYGR | Voyager Therapeutics, Inc. | NEUROCRINE BIOSCIENCES INC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $8.88 | 4,395,588 | $39,032,821 | 8,575,316 | +105.2% |
| 2023-02-25 01:12 | 2023-02-23 | EPSN | Epsilon Energy Ltd. | Solas Capital Management, LLC | 10% owner | Crude Petroleum & Natural Gas | BUY | $5.45 | 300,000 | $1,635,000 | 3,608,467 | +9.1% |
| 2023-02-24 04:51 | 2023-02-17 | IGTA | Inception Growth Acquisition Ltd | Soul Venture Partners LLC | 10% owner | Blank Checks | BUY | $1,352.66 | 140,000 | $189,372,400 | 2,507,500 | +5.9% |
| 2023-02-24 01:21 | 2023-02-21 | LNKB | LINKBANCORP, Inc. | Parmer George | Director | State Commercial Banks | BUY | $7.80 | 961,538 | $7,499,996 | 981,538 | +4,807.7% |
| 2023-02-24 01:52 | 2023-02-22 | ET | Energy Transfer LP | WARREN KELCY L | Director, Officer - Executive Chairman | Natural Gas Transmission | BUY | $12.99 | 1,339,398 | $17,398,780 | 56,917,875 | +2.4% |
| 2023-02-24 01:03 | 2023-02-23 | PI | IMPINJ INC | SANGHI STEVE | Director | Electronic Components, NEC | BUY | $119.70 | 16,700 | $1,998,990 | 16,700 | +100.0% |
| 2023-02-23 01:14 | 2023-02-21 | VPG | Vishay Precision Group, Inc. | Cummins Wes | Director | Electronic Components & Accessories | BUY | $42.49 | 25,000 | $1,062,273 | 431,792 | +6.1% |
| 2023-02-22 04:55 | 2023-02-21 | RCM | N/A | RIVAS LEE | Director, Officer - Chief Executive Officer | Other | BUY | $13.93 | 71,767 | $1,000,001 | 71,767 | +100.0% |
| 2023-02-22 05:00 | 2023-02-17 | DISTU | N/A | Zhang Jian | Director, Officer, 10% owner - CEO and Chairman | Other | BUY | $10.00 | 545,000 | $5,450,000 | 2,270,000 | +31.6% |
| 2023-02-22 02:08 | 2023-02-16 | BY | BYLINE BANCORP, INC. | DEL VALLE PEROCHENA ANTONIO | Director, 10% owner | State Commercial Banks | BUY | $24.99 | 45,000 | $1,124,663 | 11,645,601 | +0.4% |
| 2023-02-22 02:07 | 2023-02-16 | BY | BYLINE BANCORP, INC. | MBG INVESTORS I, L.P. | 10% owner | State Commercial Banks | BUY | $24.99 | 45,000 | $1,124,663 | 11,645,601 | +0.4% |
| 2023-02-22 00:08 | 2023-02-17 | VPG | Vishay Precision Group, Inc. | Cummins Wes | Director | Electronic Components & Accessories | BUY | $42.26 | 25,000 | $1,056,575 | 406,792 | +6.5% |
| 2023-02-22 00:19 | 2023-02-16 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $3.17 | 2,208,000 | $6,999,360 | 6,722,336 | +48.9% |
| 2023-02-22 01:23 | 2023-02-16 | APPN | Appian Corporation | Abdiel Capital Advisors, LP | 10% owner | Services-Prepackaged Software | BUY | $45.21 | 100,000 | $4,520,800 | 10,115,510 | +1.0% |
| 2023-02-17 16:25 | 2023-02-16 | ISSC | INNOVATIVE SOLUTIONS & SUPPORT INC | Harborne Christopher | 10% owner | Services-Computer Programming Services | BUY | $7.75 | 134,504 | $1,042,393 | 2,506,322 | +5.7% |
| 2023-02-18 00:48 | 2023-02-15 | IRON | Disc Medicine, Inc. | Ashiya Mona | Director, 10% owner | Pharmaceutical Preparations | BUY | $23.00 | 108,696 | $2,500,008 | 299,205 | +57.1% |
| 2023-02-17 20:52 | 2023-02-07 | BTMD | biote Corp. | Roystone Capital Management LP | 10% owner | Medicinal Chemicals & Botanical Products | BUY | $3.25 | 375,000 | $1,218,750 | 2,971,566 | +14.4% |
| 2023-02-18 00:42 | 2023-02-15 | IRON | Disc Medicine, Inc. | AI DMI LLC | 10% owner | Pharmaceutical Preparations | BUY | $23.00 | 434,783 | $10,000,009 | 3,141,759 | +16.1% |
| 2023-02-18 00:13 | 2023-02-16 | N/A | N/A | Golub Lawrence E | Director, Officer, 10% owner - CHAIRMAN | Other | BUY | $15.00 | 133,347 | $2,000,210 | 1,605,288 | +9.1% |
| 2023-02-18 00:10 | 2023-02-16 | N/A | N/A | Golub David | Director, Officer, 10% owner - President, CEO | Other | BUY | $15.00 | 133,347 | $2,000,210 | 1,605,288 | +9.1% |
| 2023-02-18 03:41 | 2023-02-17 | PYPL | PayPal Holdings, Inc. | SCHULMAN DANIEL H | Director, Officer - President and CEO | Services-Business Services, NEC | BUY | $76.17 | 26,065 | $1,985,306 | 395,351 | +7.1% |
| 2023-02-18 00:43 | 2023-02-15 | IRON | Disc Medicine, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $23.00 | 108,696 | $2,500,008 | 299,205 | +57.1% |
| 2023-02-18 01:29 | 2023-02-15 | GLYC | CRESCENT BIOPHARMA, INC. | Invus Public Equities, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $2.00 | 1,515,266 | $3,027,956 | 8,089,064 | +23.1% |
| 2023-02-17 00:54 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 250,000 | $4,000,000 | 9,194,579 | +2.8% |
| 2023-02-17 04:53 | 2023-02-14 | BHM | Bluerock Homes Trust, Inc. | Sanda Par Olof | 10% owner | Real Estate Investment Trusts | BUY | $20.44 | 113,283 | $2,315,618 | 463,445 | +32.4% |
| 2023-02-17 01:54 | 2023-02-14 | NSIT | INSIGHT ENTERPRISES INC | ValueAct Holdings, L.P. | Director, Other | Retail-Catalog & Mail-Order Houses | BUY | $127.76 | 85,355 | $10,905,168 | 4,507,306 | +1.9% |
| 2023-02-17 01:04 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Pharmaceutical Preparations | BUY | $16.00 | 1,250,000 | $20,000,000 | 1,311,247 | +2,040.9% |
| 2023-02-16 16:31 | 2023-02-14 | CMPR | CIMPRESS plc | Keane Robert S | Director, Officer - CEO, Chairman | Commercial Printing | BUY | $37.38 | 37,900 | $1,416,823 | 220,503 | +20.8% |
| 2023-02-17 01:35 | 2020-08-31 | N/A | N/A | WEBSTER WILLIAM M IV | Director | Other | BUY | $14.97 | 97,054 | $1,452,470 | 103,770 | +1,445.0% |
| 2023-02-17 00:54 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 937,500 | $15,000,000 | 4,519,361 | +26.2% |
| 2023-02-17 05:00 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | HBM Healthcare Investments (Cayman) Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 312,500 | $5,000,000 | 3,218,106 | +10.8% |
| 2023-02-16 20:37 | 2023-02-14 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% owner | Pharmaceutical Preparations | BUY | $5.07 | 500,000 | $2,532,600 | 9,579,963 | +5.5% |
| 2023-02-17 05:57 | 2022-02-13 | PI | IMPINJ INC | Sylebra Capital Ltd | 10% owner | Electronic Components, NEC | BUY | $125.13 | 111,697 | $13,976,389 | 2,848,085 | +4.1% |
| 2023-02-15 01:04 | 2023-02-13 | N/A | N/A | KLIKSBERG RUBEN | Director, Officer - Co-Chairman and Co-President | Other | BUY | $13.48 | 91,803 | $1,237,500 | 451,834 | +25.5% |
| 2023-02-14 14:23 | 2021-03-09 | VAQC | N/A | Vector Acquisition Partners II, L.P. | 10% owner | Other | BUY | $10.00 | 1,100,000 | $11,000,000 | 1,100,000 | +100.0% |
| 2023-02-15 02:35 | 2023-02-10 | PET | N/A | Yee Brian | Director | Other | BUY | $2.64 | 992,436 | $2,620,031 | 992,436 | +100.0% |
| 2023-02-15 02:33 | 2023-02-10 | PET | N/A | Stanford Scott | 10% owner | Other | BUY | $2.64 | 992,436 | $2,620,031 | 992,436 | +100.0% |
| 2023-02-15 02:30 | 2023-02-10 | FRSH | Freshworks Inc. | WestBridge Crossover Fund, LLC | 10% owner | Services-Prepackaged Software | BUY | $15.78 | 279,564 | $4,412,470 | 16,512,210 | +1.7% |
| 2023-02-15 01:53 | 2023-02-10 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | Deer Park Road Management Company, LP | 10% owner, Other | Services-Miscellaneous Business Services | BUY | $4.98 | 441,000 | $2,194,504 | 4,236,899 | +11.6% |
| 2023-02-14 17:23 | 2023-02-13 | LGTO | Southland Holdings, Inc. | Pratt Brian | Director, Other | Heavy Construction Other Than Bldg Const - Contractors | BUY | $10.30 | 484,436 | $4,989,691 | 484,436 | +100.0% |
| 2023-02-15 00:10 | 2023-02-10 | FBIO | Fortress Biotech, Inc. | ROSENWALD LINDSAY A MD | Director, Officer, 10% owner - President, CEO & Chairman | Pharmaceutical Preparations | BUY | $0.84 | 2,395,209 | $2,000,000 | 15,349,091 | +18.5% |
| 2023-02-15 05:05 | 2023-01-20 | PRCH | Porch Group, Inc. | Park West Asset Management LLC | 10% owner | Services-Prepackaged Software | BUY | $2.47 | 2,172,844 | $5,358,233 | 12,267,707 | +21.5% |
| 2023-02-14 16:31 | 2023-02-13 | PRPL | Purple Innovation, Inc. | Coliseum Capital Management, LLC | Director, 10% owner | Household Furniture | BUY | $4.50 | 5,960,320 | $26,821,440 | 46,814,450 | +14.6% |
| 2023-02-15 00:31 | 2023-02-10 | ANNX | Annexon, Inc. | Satter Muneer A | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.80 | 2,647,058 | $17,999,994 | 7,056,024 | +60.0% |
| 2023-02-14 19:25 | 2023-02-10 | CMPR | CIMPRESS plc | Keane Robert S | Director, Officer - CEO, Chairman | Commercial Printing | BUY | $37.60 | 31,556 | $1,186,392 | 182,603 | +20.9% |
| 2023-02-15 05:03 | 2022-02-13 | PI | IMPINJ INC | Sylebra Capital Ltd | 10% owner | Electronic Components, NEC | BUY | $125.13 | 111,697 | $13,976,389 | 2,768,085 | +4.2% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.